Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

Fig. 2

Time Course to Absence of Photophobia (A), Phonophobia (B), and Nausea (C). *P < 0.05, **P < 0.01, ***P < 0.001 vs placebo in analysis censoring for use of rescue medication. Analyses were conducted in patients experiencing the corresponding symptom with their qualifying migraine. The teal/gray bars represent the percentage of patients achieving absence of photophobia (A), phonophobia (B), and nausea (C) without rescue medication use prior to the achievement. The white bars represent the percent of patients achieving absence of photophobia (A), phonophobia (B), and nausea (C) regardless of rescue medication use

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us